Jean-François Liégeois

5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

Jean-François Liégeois, Junji Ichikawa, Herbert Y. Meltzer · Brain Research · 2002 · 132 citations

Haloperidol-induced Dopamine Release, Neuropsychology, Neurophysiology +13

Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test

Jacques Bruhwyler, E. Chleide, Jean-François Liégeois et al. · Pharmacology Biochemistry and Behavior · 1990 · 55 citations · Full text

Open-field Test, Psychoactive Drug, Psychiatry +14

Analogues of torasemide — structure function relationships —experiments in the thick ascending limb of the loop of Henle of rabbit nephron

M. Wittner, Antonio Di Stefano, Philine Wangemann et al. · Pflügers Archiv - European Journal of Physiology · 1987 · 44 citations

Mechanobiology, Physiology, Molecular Biology +4

New Pyridobenzodiazepine Derivatives:  Modifications of the Basic Side Chain Differentially Modulate Binding to Dopamine (D_4.2, D_2L) and Serotonin (5-HT_2A) Receptors

Jean-François Liégeois, Laurence Douziech-Eyrolles, Bart Ellenbroek et al. · Journal of Medicinal Chemistry · 2002 · 24 citations · Full text

JL 13, a Potential Successor to Clozapine, Is Less Sensitive to Oxidative Phenomena

Jean-François Liégeois, Ange Mouithys‐Mickalad, Jacques Bruhwyler et al. · Biochemical and Biophysical Research Communications · 1997 · 15 citations

Molecular Pharmacology, Biochemistry, Medicine +13